Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 12Glioblastoma 12Carcinoma, Non-Small-Cell Lung 12Prostatic Neoplasms 11Oropharyngeal Neoplasms 10Breast Neoplasms 10Glioma 8Urinary Bladder Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Sarcoma 5Neoplasm Metastasis 5Mouth Neoplasms 5Carcinoma 5Burkitt Lymphoma 5Astrocytoma 5Uterine Cervical Neoplasms 4Rhabdomyosarcoma 4Pancreatic Neoplasms 4Liposarcoma 4Laryngeal Neoplasms 4Histiocytoma, Malignant Fibrous 4Gliosarcoma 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Adenocarcinoma of Lung 4Adenocarcinoma Of Esophagus 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Sarcoma, Synovial 3

Interventions

nilutamide 1luprolide acetate gel depot 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Salicylic Acid 1Radiation 1Leuprolide 1Goserelin 1Flutamide 1Docetaxel 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stage I Prostate Adenocarcinoma AJCC v7 × Radiation × 90 days × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡